Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-25

Clinical Trial Update: Real-world Study on the Effectiveness and Safety of Control-IQ Technology in Teenagers With Type 1 Diabetes Engaging in Regular Physical Activity

View source ↗

Summary

A real-world study is planned to evaluate the effectiveness and safety of Medtronic's Control-IQ Technology in teenagers with Type 1 Diabetes who engage in regu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Control-IQ Technology

Snippet

Sponsor: Bruno Bombaci | Conditions: Type 1 Diabetes Mellitus | Status: RECRUITING